GlassScriptPhysician profile
Rachel E Karr
NPI 1881474054
$778.95
in general payments reported to CMS, 2019-2025
19 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $31.53 · 2024: $419 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $98.41 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Bioventus LLC | $73.38 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $72.60 | 2024-2025 | Physio-Stim, Accelstim |
| Vertex Pharmaceuticals Incorporated | $70.94 | 2025 | |
| Smith+Nephew, INC. | $65.37 | 2023-2024 | Grafix Pl, Q-Fix, Bone Anchors With Arthroscopic Delivery System |
| Pacira Pharmaceuticals Incorporated | $52.35 | 2024-2025 | Exparel, Iovera |
| Integra Lifesciences Corporation | $51.40 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Treace Medical Concepts, INC. | $41.70 | 2025 | |
| Polynovo North America LLC | $39.35 | 2024 | Novosorb Btm |
| Paratek Pharmaceuticals, INC. | $30.72 | 2024 | Nuzyra |
| Reprise Biomedical, INC. | $30.44 | 2025 | Miro3d |
| Medtronic, INC. | $25.80 | 2024 | Intellis Adaptivestim |
| Boston Scientific Corporation | $23.43 | 2024 | |
| Convatec INC. | $21.23 | 2024 | |
| Djo, LLC | $18.91 | 2024 | Cmf |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $18.56 | 2024 | Qutenza |
| Ani Pharmaceuticals, INC. | $17.62 | 2025 | Purified Cortrophin Gel |
| Mimedx Group, INC. | $13.48 | 2024 | |
| Nalu Medical, INC. | $13.26 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Karr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.